Continuum Advisory LLC trimmed its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 95.2% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,576 shares of the exchange traded fund’s stock after selling 31,453 shares during the quarter. Continuum Advisory LLC’s holdings in SPDR S&P Biotech ETF were worth $142,000 as of its most recent filing with the SEC.
Other large investors have also recently made changes to their positions in the company. Kohmann Bosshard Financial Services LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth approximately $29,000. Golden State Wealth Management LLC purchased a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at $29,000. Avior Wealth Management LLC grew its holdings in SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after buying an additional 307 shares in the last quarter. Lee Danner & Bass Inc. purchased a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at $38,000. Finally, Bank of Jackson Hole Trust purchased a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at $43,000.
SPDR S&P Biotech ETF Stock Down 0.1%
Shares of NYSEARCA:XBI opened at $79.25 on Friday. The business has a fifty day moving average of $79.30 and a two-hundred day moving average of $88.08. The stock has a market cap of $4.99 billion, a P/E ratio of 11.47 and a beta of 0.91. SPDR S&P Biotech ETF has a 52-week low of $66.66 and a 52-week high of $105.47.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Turbulence for Joby Shares: What’s Behind the Recent Dip?
- 3 Healthcare Dividend Stocks to Buy
- Why Carnival Could Be the Ultimate Non-Tech Growth Stock
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Super Micro Computer Stock Clears New Path Higher on Saudi Orders
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.